Logo

Blog

Advocacy and research – August 2017

Participate in the Canadian Food Inspection Agency’s open consultation on allergen labelling for beer – open until August 15, read about Hamilton Ontario’s stock epinephrine auto-injector project, learn more about our work on a global study to review epinephrine availability, and read about a study from AllerGen NCE Inc. that finds delaying food introduction increases the risk of sensitization.


Allergen labelling for beer: Open consultation until August 15

The Canadian Food Inspection Agency (CFIA) is requesting public input by August 15 on the proposed changes they want to make to the Food and Drug Regulations so beer compositional standards can be updated.

One of the considerations with this consultation is to review allergen, gluten, and sulphite labelling on standardized beer. Currently, standardized beer is exempt from this labelling, however, with this consultation, you can help to change that. This is the opportunity to have your say.

Learn more and provide your feedback to the CFIA.


Hamilton Ontario’s stock epinephrine auto-injector project

The city of Hamilton, Ontario is looking to roll out a stock epinephrine program to 50 restaurants. Stock epinephrine is an epinephrine auto-injector (e.g. EpiPen®) that is not prescribed to anyone and can be used in an emergency. We are supporting this very important initiative by offering free training to the participating restaurants.

Read more


Award winning: Global review of epinephrine availability and anaphylaxis management practices study

Dr. Susan Waserman, Principal Investigator, McMaster University in Hamilton, ON and other international co-investigators conducted a study to better understand consumer perspectives about epinephrine/adrenaline auto-injectors (EAIs/AAIs) worldwide. They collaborated with Food Allergy Canada, and other patient organizations which support individuals with food allergies, for this study.

The study was in the form of an online survey, offered in 12 languages, and was completed by almost 8,200 people in 21 countries.

We were pleased that the e-poster of this study was selected from amongst 15 posters that were presented on June 19th at the European Academy of Allergy and Clinical Immunology (EAACI) 2017 Congress in Helsinki, Finland. Criteria included the quality and usefulness of the research and the presentation itself.

This study identifies the most common challenges faced by at-risk individuals including EAI availability, cost, and concerns over short expiry dates. We will use the results of this study to identify potential solutions to address common challenges, including sub-optimal use of EAIs during an emergency.

Read the abstract that was submitted.   


Study finds delayed food introduction increases risk of sensitization

AllerGen NCE Inc., a national research network, recently noted that delaying the introduction of potentially allergenic foods until after a baby’s first year may increase the likelihood of a food allergy later on, according to new findings from the Canadian Healthy Infant Longitudinal Development (CHILD) Study.

Read more